Global Non-Hodgkin Lymphoma Diagnostics Market: Global Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2012 to 2016 and Forecast 2017 to 2023

Global Non-Hodgkin Lymphoma Diagnostics Market:By Type (Lymph Node Biopsy (Immunophenotyping, Cytogenetic Analysis, Gene Expression Profiling, Microarray analysis), (Physical Imaging (MRI Scanning, CT-Scan, X-rays, Fluorodeoxyglucose Positron Emission Tomography (FDG-PET), Blood Tests)), By Type of NHL (B-Cell Non-Hodgkin Lymphoma (Diffuse Large B-Cell Lymphoma, Burkitt Lymphoma, Mantel Cell Lymphoma, Primary Central Nervous System Lymphoma), (T-Cell Non-Hodgkin Lymphoma (Peripheral T-Cell Lymphoma not Otherwise Specified, Anaplastic Large Cell Lymphoma, Angioimmunoblastic T-Cell Lymphoma, Enteropathy-Associated T-Cell Lymphoma, Adult T-Cell Lymphoma, Nasal type NK/T-Cell Lymphoma, Hepatosplenic T-Cell Lymphoma), By Category of Condition (Category A, Category B, Category X, Category E), By End User (Hospitals, Diagnostic Centers, Clinics), and Geography -Non-Hodgkin Lymphoma Diagnostics Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis2012 to 2016 and Forecast 2017 to 2023

Non-Hodgkin Lymphoma Diagnostics Market: Market Dynamics

Non-Hodgkin’s lymphoma is a cancer which originates in lymphatic system. Non-Hodgkin’s lymphoma tumors develop from lymphocytes. It is more common than Hodgkin’s lymphoma. There are several type of non-Hodgkin lymphomas, among them follicular lymphoma ad Diffuse B-Cell lymphoma are most common subtypes. Symptoms may include painless swelling of limp nodes in neck, armpits or groin, abdominal pain, chest pain and others.Increasing prevalence of Non-Hodgkin’s lymphoma globally is one of the major factor which is attributing for the growth of the Non-Hodgkin’s lymphoma diagnostics market. According to Leukaemia and Lymphoma Society, NHL is the 7th most common cancer in U.S and 5th in UK. As per to the American cancer Society, 20150 deaths were recorded in U.S due to NHL in 2016. Moreover, Growing awareness and concern about the disease, increase in healthcare expenditure, rise in advancements in the technologies and innovation of new products, large number of unmet needs related to the disease are the few factors which are propelling the growth of the Non-Hodgkin’s lymphoma diagnostics market. However, limited options for the treatment, inaccurate and inadequate results of the diagnosis, high cost associated with the tests are the few factors which are restraining the growth of the Non-Hodgkin’s lymphoma diagnostics market.

A sample of this report is available upon request @
https://www.precisionbusinessinsights.com/market-reports/global-non-hodgkin-lymphoma-diagnostics-market/#ulp-4H8Z4LpNMLEuOnnx

Market Scope: Non-Hodgkin Lymphoma Diagnostics Market
Non-Hodgkin Lymphoma Diagnostics Marketis segmented on the basis of Type, Type of NHL, Category of Condition, End User and Geographical regions
Based on the Type, Non-Hodgkin Lymphoma Diagnostics Marketis segmented into the following:
• Lymph Node Biopsy
• Immunophenotyping
• Cytogenetic Analysis
• Gene Expression Profiling
• Microarray analysis
• Physical Imaging
• MRI Scanning
• CT-Scan
• X-rays
• Fluorodeoxyglucose Positron Emission Tomography (FDG-PET)
• Blood Tests
Based on the Type of NHL, Non-Hodgkin Lymphoma Diagnostics Market is segmented into the following:
• B-Cell Non-Hodgkin Lymphoma
• Diffuse Large B-Cell Lymphoma
• Burkitt Lymphoma
• Mantel Cell Lymphoma
• Primary Central Nervous System Lymphoma
• T-Cell Non-Hodgkin Lymphoma
• Peripheral T-Cell Lymphoma not Otherwise Specified
• Anaplastic Large Cell Lymphoma
• Angioimmunoblastic T-Cell Lymphoma
• Enteropathy-Associated T-Cell Lymphoma
• Adult T-Cell Lymphoma
• Nasal type NK/T-Cell Lymphoma
• Hepatosplenic T-Cell Lymphoma
Based on the Category of Condition, Non-Hodgkin Lymphoma Diagnostics Market is segmented into the following:
• Category A
• Category B
• Category X
• Category E
Based on the End User, Non-Hodgkin Lymphoma Diagnostics Marketis segmented into the following:
• Hospitals
• Diagnostic Centers
• Clinics

To view TOC of this report is available upon request @
https://www.precisionbusinessinsights.com/market-reports/global-non-hodgkin-lymphoma-diagnostics-market/#ulp-c654SbFYO64MsOhu

Regional Analysis: Non-Hodgkin Lymphoma Diagnostics Market
Geographically, Non-Hodgkin Lymphoma Diagnostics Marketis segmented into North America, Europe, Asia Pacific, Latin America, and theMiddle East and Africa regions.North America dominates the global market for Non-Hodgkin Lymphoma Diagnostics market due to growing prevalence of Non-Hodgkin Lymphoma cases and technological advancements in the region, heavy investments in R & D activities along with government support will boost the industry demand over the coming years. The Europe market is anticipated to grow rapidly over the forecast timeline due to the rising occurrence of Non-Hodgkin Lymphoma along with increasing acceptance of gene technology. Asia is expected to witness high growth in Non-Hodgkin Lymphoma Diagnostics market, due to increasing government initiatives, rising economy, and improvement in healthcare infrastructure in the region.Some of the key driving forces for Non-Hodgkin Lymphoma Diagnostics market in emerging countries are increasing R&D investment, a large pool of patients and rising government funding.

Competition Assessment: Non-Hodgkin Lymphoma Diagnostics Market
Key playersprofiled in the global Non-Hodgkin Lymphoma Diagnostics Marketinclude:
• Novartis AG (Switzerland)
• Amgen, Inc.(U.S)
• Abbott Laboratories, Inc.(U.S)
• Eli Lilly and Company(U.S.)
• AstraZeneca plc (U.K)
• Illumina, Inc.(U.S)
• Genoptix, Inc. (U.S.)
• bioMeriux SA (France)
• Pfizer, Inc. (U.S.)
• Hoffmann-La Roche Ltd. (Switzerland)
• GlaxoSmithKline plc (UK)
• Celgene corporation (U.S)

Need more information about this report @
https://www.precisionbusinessinsights.com/market-reports/global-non-hodgkin-lymphoma-diagnostics-market/#ulp-14mlyhjMGhVjZqa3

Key Features of the Report:
• The report provides granular level information about the market size, regional market share, historic market (2012-2016) and forecast (2017-2023)
• The report covers in-detail insights about the competitor’s overview, company share analysis, key marketdevelopments, and their key strategies
• The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
• The report tracks recent innovations, key developments and startup’s details that are actively working in the market
• The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario
• The report analyses the impact of socio-political environment through PESTLE Analysis and competition through Porter’s Five Force Analysis in addition to recent technology advancements and innovations in the market

Get access to full summary @
https://www.precisionbusinessinsights.com/market-reports/global-non-hodgkin-lymphoma-diagnostics-market/

About Precision Business Insights

Precision Business Insights is one of the leading market research and business consulting firm, which follow a holistic approach to solve needs of the clients. We adopt and implement proven research methodologies to achieve better results. We help our clients by providing actionable insights and strategies to make better decisions. We provide consulting, syndicated and customised market research services based on our client needs.

Contact to Precision Business Insights,

Kemp House,
152 – 160 City Road,
London EC1V 2NX

Email: sales@precisionbusinessinsights.com

Toll Free (US): +1-866-598-1553
Website @ https://www.precisionbusinessinsights.com

This release was published on openPR.